In an interview with InsideHook, SōRSE’s Director of Research and Analytics and in-house Flavorist, Donna Wamsley, explains how and why things taste the way they taste, trends in the flavor industry, and what’s next in the world of cannabis food and beverage.
Over the past year, there has been a significant rise in sales of packaged beverages over dispensed since consumers are spending far more time at home. Our COO, Tyler Peterson, shares his insights on how store operators can best take advantage of these dynamics for more sales and profit.
“We’re just trying to offer the opportunity to make products with a top of the line water-soluble format and to be able to wholesale our emulsion to other clients in your state.” – Zach Hershberger, SōRSE’s Operations Manager.
Learn more about SōRSE’s mobile unit – how it’s a new way for SōRSE to work with our partners at a time when CBD and cannabis co-packers are unevenly distributed and regulated across the country.
In an interview with Food Engineering Magazine, SōRSE’s CEO, Howard Lee, explains the development of SōRSE Clear, and the challenges that had to be overcome when creating it.
SEATTLE–SōRSE Technology, the leading water-soluble emulsion technology designed for infusing functional ingredients into consumer goods, announces the addition of 7.5% CBD liquid emulsion for personal care products to their product suite. SōRSE is designed for product developers to make oil-based functional ingredients water-soluble and more efficacious, while also providing the consumer with a consistent, safe experience.
SōRSE, which currently powers over 60 infused products on the market, developed the 7.5% CBD emulsion for the personal care category to eliminate the current market’s sticky and unstable formulations. Personal care products offer a delivery method consumers are comfortable with and purchase frequently; consumers also expect an enjoyable and consistent experience just as they do with beverages and food items. SōRSE’s 7.5% water-soluble CBD emulsion seamlessly integrates, complements other ingredients, and can be modified for multiple SKUs.
“While we are a functional ingredient supplier, our foundation is in water-soluble emulsion technology and product development,” commented CEO Howard Lee. “It’s through our technology that we’re changing how the personal care industry works with tricky functional ingredients like CBD that consumers demand. We’ve made working with our technology and ingredients simple so that we can focus on helping our partners deliver more enjoyable, more effective products.”
SōRSE Technology is hosting a webinar on Thursday, February 25th on the benefits of water-soluble emulsion technology for personal care products to educate product developers on their new 7.5% CBD emulsion solution. Those interested in attending can register here or contact SōRSE directly at firstname.lastname@example.org for more information.
About SōRSE Technology
SōRSE Technology is the leading water-soluble emulsion technology designed for infusing functional ingredients into beverages, food items, personal care products, and medical applications. SōRSE is designed for product developers to make oil-based functional ingredients water-soluble and more efficacious, while also providing the consumer with a consistent, safe, and enjoyable experience. With over 200 years’ experience in food & beverage and an R&D team of 30+ employees, SōRSE is a partner that can take a producer from concept to commercialization quickly and efficiently.
In a recent interview with The Fly, our CEO, Howard Lee, shares why SōRSE has “more resiliency in our system than any other (emulsion) provider today” along with challenges and opportunities we face.
Participating in Dry January? WSPA-TV News Channel 7 based in South Carolina, recently featured a segment on Dry January Beverage Ideas and highlights SōRSE and describes some of our partners’, Aprch™ Beverage Co. , Kleer Sparkling Water and Mad Tasty as hydrating and restorative alternatives.
SEATTLE & VANCOUVER, British Columbia–Pascal Biosciences Inc. (TSX.V:PAS) (OTC:BIMUF) (“Pascal” or the “Company”) and SōRSE Technology Corporation (“SōRSE”) have validated and optimized a formula for oral cannabinoid delivery. Their shared efforts are advancing the cannabinoid PAS-393 towards clinical testing against cancer.
“This progress is very promising because this step is critical for testing in human volunteers,” said Pascal CEO Patrick Gray. “We will next identify a drug product manufacturer to prepare our product for testing in cancer patients treated with checkpoint inhibitors.”
It will be the first pharmaceutical use of the novel formulation technology developed by SōRSE and the first clinical trial for Pascal and SōRSE. This collaboration utilizes propriety discoveries by both companies, including Pascal’s intellectual property, which covers the use of cannabinoids in cancer patients treated with checkpoint inhibitors, and SōRSE’s proprietary formulation expertise.
“It’s great to see such rapid progress with the in vitro studies using our formulation technology,” said SōRSE CEO Howard Lee. “We are on track to enter our first clinical trial with Pascal within a year.”
Following characterization of safety and pharmacology in a Phase 1a clinical trial, Pascal and SōRSE may elect to continue clinical development as equal partners in a Phase 1b cancer trial in combination with a checkpoint inhibitor.
About Pascal Biosciences Inc.
Pascal is a biotechnology company targeting innovative therapies for serious diseases, including COVID-19. Pascal is also developing treatments for cancer with targeted therapies for acute lymphoblastic leukemia and cannabinoid-based therapeutics. Pascal’s leading portfolio also comprises a small molecule therapeutic, PAS-403, that is advancing into clinical trials for the treatment of glioblastoma, and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy. For more information, visit www.pascalbiosciences.com.
About SōRSE Technology
SōRSE Technology Corporation is a water-soluble emulsion technology designed for product developers to provide consumers with a better, more consistent cannabinoid experience with greater bioavailability, near-perfect dosing, shelf-stability, and safe ingredients. Its patent-pending technology converts oil into SōRSE, a proprietary water-soluble emulsion, for infusing CBD and other functional ingredients into beverages, food items, topicals, and medical applications. SōRSE Technology currently powers more than 45 leading products in the CBD space. For more information, visit www.sorsetechnology.com.
SōRSE Technology Press:
Jon Lindsay Phillips
An article in The Tasting Panel Magazine highlighted SōRSE and its partners Aprch™ Beverage Co. , Kleer Sparkling Water and MAD TASTY, commenting, “SōRSE’s success in developing emulsions and flavor profiles that make it convenient for manufacturers to incorporate broad-spectrum #CBD is paving the way for more functional products across a variety of categories.”
Our Process Engineering Manager, Emily Skrobecki, shared her thoughts with BizWomen on how Covid has impacted the way she works with the team and how she prioritizes aspects of her job. Read the full article.